Strategy Asset Managers LLC Has $1.06 Million Stake in Colgate-Palmolive (NYSE:CL)

Strategy Asset Managers LLC raised its holdings in Colgate-Palmolive (NYSE:CL) by 165.7% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 10,242 shares of the company’s stock after acquiring an additional 6,388 shares during the quarter. Strategy Asset Managers LLC’s holdings in Colgate-Palmolive were worth $1,063,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Price T Rowe Associates Inc. MD raised its holdings in Colgate-Palmolive by 27.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after acquiring an additional 8,933,912 shares in the last quarter. Swedbank AB bought a new stake in shares of Colgate-Palmolive during the 1st quarter worth approximately $286,370,000. Acadian Asset Management LLC boosted its holdings in shares of Colgate-Palmolive by 108.4% in the 2nd quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock valued at $551,367,000 after buying an additional 2,955,442 shares during the last quarter. Massachusetts Financial Services Co. MA grew its stake in shares of Colgate-Palmolive by 40.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company’s stock valued at $870,400,000 after buying an additional 2,593,313 shares in the last quarter. Finally, AQR Capital Management LLC increased its holdings in Colgate-Palmolive by 58.6% during the second quarter. AQR Capital Management LLC now owns 2,416,943 shares of the company’s stock worth $234,540,000 after buying an additional 892,706 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have commented on the stock. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and increased their price target for the company from $107.00 to $109.00 in a research note on Monday, September 9th. Hsbc Global Res downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. UBS Group boosted their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Jefferies Financial Group cut Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their price objective for the company from $103.00 to $95.00 in a research report on Wednesday, July 24th. Finally, Wells Fargo & Company decreased their target price on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus target price of $105.11.

Colgate-Palmolive Stock Down 1.1 %

NYSE CL opened at $93.61 on Wednesday. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. The company has a market cap of $76.48 billion, a price-to-earnings ratio of 26.82, a PEG ratio of 3.34 and a beta of 0.42. The company has a 50 day moving average of $98.80 and a 200-day moving average of $98.56. Colgate-Palmolive has a 1-year low of $75.17 and a 1-year high of $109.30.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $0.50 dividend. The ex-dividend date was Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.14%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Activity

In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the company’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 16.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.37% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.